{
	"slug": "cancer-neutropenic-fever",
	"title": "Neutropenic Fever and Cancer",
	"authors": [
		"Michelle Lin, MD"
	],
	"categories": [
		{
			"slug": "hematology-and-oncology",
			"name": "Hematology and Oncology"
		}
	],
	"created": "2011/10/07",
	"updates": [
		"2017/05/10"
	],
	"body": "\n# Neutropenic Fever and Cancer\n\nChemotherapy causes neutropenia in 10-50% of patients with solid tumors and > 80% of patients with hematologic malignancies during chemotherapy cycle\n\n**Fever:** &ge; 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period\n\n**Neutropenia:** Absolute neutrophil count &lt; 500 cells/mm3\n\n## MASCC score\n\n**Multinational Association for Supportive Care in Cancer (MASCC) Score**\n\n| Criteria                                                                                          |                         Points |\n| ------------------------------------------------------------------------------------------------- | -----------------------------: |\n| Burden of febrile neutropenia                                                                     | 5 (if mild) or 3 (if moderate) |\n| No hypotension (SBP ≥ 90 mmHg)                                                                    |                              5 |\n| No COPD                                                                                           |                              4 |\n| Solid tumor or hematologic malignancy <span class=\"drug\">with</span> no previous fungal infection |                              4 |\n| No dehydration requiring parenteral fluids                                                        |                              3 |\n| Outpatient status                                                                                 |                              3 |\n| Age &lt;60 years                                                                                  |                              2 |\n\n### High Risk Patients (require admission)\n\n- MASCC score &lt;21 **OR**\n- Any of clinical findings:\n  - Prolonged (>7 days duration) and profound neutropenia (ANC ≤100 cells/mm3)\n  - Hypotension\n  - Pneumonia\n  - New abdominal pain\n  - Neurologic changes\n\n### Low Risk Patients (may be eligible for outpatient tx)\n\n- MASCC score &ge;21\n- Brief (&le;7 days duration) neutropenic periods and few co-morbidities\n\n## Workup\n\n- CBC, BUN/creatinine, electrolytes, AST/ALT, bilirubin\n- Chest xray, if respiratory signs or symptoms\n- 2 blood cultures (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)\n\n## Antibiotic Treatment\n\n### Monotherapy\n\n- Antipseudomonal beta-lactam (eg. <span class=\"drug\">cefipime</span>, <span class=\"drug\">carbapenem</span>, <span class=\"drug\">pip-tazo</span>)\n- <span class=\"drug\">Vancomycin</span> is not always indicated in cancer patients with a neutropenic fever.\n- Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant _Strep pneumoniae_\n- _For penicillin allergy_: <span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">clindamycin</span>, or <span class=\"drug\">aztremonam</span> + <span class=\"drug\">vancomycin</span>\n- _Oral medication options for outpatient_: <span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">amoxicillin-clavulanate</span>\n\n## Central line-associated blood stream infection (CLABSI)\n\n**Remove catheter:** Consider removal if any of following: \n\n- Caused by _S. aureus_, _P. aeruginosa_, fungi, mycobacteria\n- Tunnel infection\n- Pocket site infection\n- Septic thrombosis\n- Endocarditis\n- Sepsis with hemodynamic instability\n- Bacteremia despite ≥72 hours of antibiotics\n\n**Keep catheter** and treat with antiobitics: If coagulase-negative staph\n\n## References\n\n- Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21205990)]\n"
}